Exploring Rare Disease Breakthroughs: 2026 NORD Breakthrough Summit

Written by Allison Wu

From October 25 to October 27, 2026, Allison Wu represented Harvard Undergraduate Rare Diseases (HURD) at the 2026 National Organization for Rare Disorders (NORD) Breakthrough Summit in Washington, D.C. Through NORD's Summit Student Scholarship, Allison had the opportunity to engage with patients, advocates, researchers, healthcare professionals, and fellow student leaders dedicated to advancing rare disease research and advocacy.

During the summit, Allison presented a poster titled "HackRare at Harvard: Fostering Student-Driven Innovation for Rare Diseases" by Allison C. Wu, Adithya Madduri, Nicholas H. Dang, Timothy Guan, highlighting HURD's efforts to engage students in developing innovative, patient-centered solutions through its annual rare disease hackathon, HackRare.

The poster session provided an opportunity to introduce HackRare to members of the broader rare disease community and reconnect with individuals who have supported the event. Allison enjoyed meeting with Yojana Rodriguez-Humbert from KayaGirlLegacy and Harvard alumnus Bill Berry, learning about Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) and CG Life’s 24/364 Rare Disease Film Festival. She also reconnected with previous HackRare patient organization speakers Gay Grossman and Steve Grossman from ADCY5.org, as well as HackRare judges Edward Neilan and Julieta Bonvin Sallago. HURD was thrilled to see Julieta’s work for the rare disease community recognized with NORD's Rare Impact: Community Champion Award.

Allison also participated in the NORD Student Leaders Meeting, where she connected with fellow students passionate about rare diseases and explored topics related to rare cancers through the Living Rare Study. One highlight was reconnecting with Kritika Singh, a former HackRare 2026 participant, whose project on recurrent respiratory papillomatosis developed into a poster presented at IDWeek 2026. Her experience demonstrates how student-led initiatives such as HackRare can inspire continued research and engagement in rare diseases beyond the hackathon itself.

Beyond these connections, Allison heard from various leaders including Acting FDA Commissioner Kyle Diamantas, NIH Director Dr. Jay Battacharya, and NORD CEO Pam Gavin. These talks highlighted the complexities of advancing rare disease research and translating scientific discoveries into treatments that actually reach patients. From the importance of natural history data and innovative clinical trial designs to balancing consistency and flexibility in FDA review processes, a recurring theme was the critical role of involving patients as partners at every stage. While incredible progress has been made, there is still so much work left to be done.

The summit came at the perfect time, as our HackRare organizing team is actively developing problem statements for our four tracks: Genomic Diagnostics, Therapeutic Targets, Symptom Management, and our newest addition, Policy & Health Access! The conversations throughout the summit offered new perspectives on the challenges facing the rare disease community, and Allison looks forward to bringing these insights back to the HackRare team as we prepare for HackRare 2027.

HURD is grateful to NORD for awarding Allison a Summit Student Scholarship and providing this valuable opportunity to learn from and connect with the rare disease community. HURD looks forward to incorporating these perspectives into its hackathon problem statements and continuing to foster student involvement in rare disease research, innovation, and advocacy.

Previous
Previous

From HackRare to IDWeek: Advancing RRP Research using AI

Next
Next

The Dictionary: Fighting Rare Disease with the Power of Words